Home  |  About JAPTR |  Editorial board  |  Search |  Ahead of print  |  Current issue  |  Archives |  Submit article  |  Instructions  |  Subscribe  |  Advertise  |  Contacts  |Login 
Users Online: 256   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others


Neuroanatomical changes in Parkinson's disease in relation to cognition: An update

Prakash K G, Bannur B M, Chavan Madhavrao D, Saniya K, Sailesh Kumar Sai, Rajagopalan Archana

Year : 2016| Volume: 7| Issue : 4 | Page no: 123-126

   This article has been cited by
1 Removal of proteinase K resistant aSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse model
Tony S. Etelšinen, Tommi P. Kilpelšinen, Adele Ignatius, Samuli Auno, Francesca De Lorenzo, Johanna K. Uhari-Vššnšnen, Ulrika H. Julku, Timo T. MyŲhšnen
Neuropharmacology. 2022; 218: 109213
[Pubmed]  [Google Scholar] [DOI]
2 Brain-derived neurotrophic factor attenuates cognitive impairment and motor deficits in a mouse model of Parkinsonśs disease
E Chang,Jiongmei Wang
Brain and Behavior. 2021;
[Pubmed]  [Google Scholar] [DOI]
3 Deep brain stimulation for movement disorder treatment: exploring frequency-dependent efficacy in a computational network model
Konstantinos Spiliotis, Jens Starke, Denise Franz, Angelika Richter, RŁdiger KŲhling
Biological Cybernetics. 2021;
[Pubmed]  [Google Scholar] [DOI]
4 Dysregulation of mitochondrial and proteolysosomal genes in Parkinsonís disease myeloid cells
Elisa Navarro,Evan Udine,Katia de Paiva Lopes,Madison Parks,Giulietta Riboldi,Brian M. Schilder,Jack Humphrey,Gijsje J. L. Snijders,Ricardo A. Vialle,Maojuan Zhuang,Tamjeed Sikder,Charalambos Argyrou,Amanda Allan,Michael J. Chao,Kurt Farrell,Brooklyn Henderson,Sarah Simon,Deborah Raymond,Sonya Elango,Roberto A. Ortega,Vicki Shanker,Matthew Swan,Carolyn W. Zhu,Ritesh Ramdhani,Ruth H. Walker,Winona Tse,Mary Sano,Ana C. Pereira,Tim Ahfeldt,Alison M. Goate,Susan Bressman,John F. Crary,Lotje de Witte,Steven Frucht,Rachel Saunders-Pullman,Towfique Raj
Nature Aging. 2021; 1(9): 850
[Pubmed]  [Google Scholar] [DOI]
5 Role of neuron specific enolase as a biomarker in Parkinsonís disease
Dutta Rajib
Journal of Neuroscience and Neurological Disorders. 2021; 5(2): 061
[Pubmed]  [Google Scholar] [DOI]
6 Intersection of Redox Chemistry and Ubiquitylation: Post-Translational Modifications Required for Maintaining Cellular Homeostasis and Neuroprotection
Emma I. Kane,Kelly L. Waters,Donald E. Spratt
Cells. 2021; 10(8): 2121
[Pubmed]  [Google Scholar] [DOI]
7 3D Textural, Morphological and Statistical Analysis of Voxel of Interests in 3T MRI Scans for the Detection of Parkinsonís Disease Using Artificial Neural Networks
Sabyasachi Chakraborty,Satyabrata Aich,Hee-Cheol Kim
Healthcare. 2020; 8(1): 34
[Pubmed]  [Google Scholar] [DOI]
8 Neuroprotective and neurotoxic outcomes of androgens and estrogens in an oxidative stress environment
Phong Duong,Mavis A. A. Tenkorang,Jenny Trieu,Clayton McCuiston,Nataliya Rybalchenko,Rebecca L. Cunningham
Biology of Sex Differences. 2020; 11(1)
[Pubmed]  [Google Scholar] [DOI]
9 Investigation of anti-Parkinson activity of dicyclomine
Maham Sanawar,Uzma Saleem,Fareeha Anwar,Samra Nazir,Muhammad Furqan Akhtar,Bashir Ahmad,Tariq Ismail
International Journal of Neuroscience. 2020; : 1
[Pubmed]  [Google Scholar] [DOI]
10 Endosomal Trafficking in Alzheimerśs Disease, Parkinsonśs Disease, and Neuronal Ceroid Lipofuscinosis
Yasir H. Qureshi,Penelope Baez,Christiane Reitz
Molecular and Cellular Biology. 2020; 40(19)
[Pubmed]  [Google Scholar] [DOI]
11 Apitherapy for Parkinsonís Disease: A Focus on the Effects of Propolis and Royal Jelly
Amira Mohammed Ali,Hiroshi Kunugi,German Gil
Oxidative Medicine and Cellular Longevity. 2020; 2020: 1
[Pubmed]  [Google Scholar] [DOI]
12 Optical Coherence Tomography Angiography in Neuroophthalmology Review
Nicolas Seleme,Alvaro J. Mejia-Vergara,William Sultan,Samuel Asanad,Alfredo A. Sadun,Rustum Karanjia
Advances in Ophthalmology and Optometry. 2020;
[Pubmed]  [Google Scholar] [DOI]
13 Diffusion Kurtosis Imaging Detects Microstructural Changes in a Methamphetamine-Induced Mouse Model of Parkinsonís Disease
Anas Arab,Jana Ruda-Kucerova,Alzbeta Minsterova,Eva Drazanova,Nikoletta Szabů,Zenon Starcuk,Irena Rektorova,Amit Khairnar
Neurotoxicity Research. 2019;
[Pubmed]  [Google Scholar] [DOI]
14 Proteomics in Human Parkinsonís Disease: Present Scenario and Future Directions
Anubhuti Dixit,Rachna Mehta,Abhishek Kumar Singh
Cellular and Molecular Neurobiology. 2019;
[Pubmed]  [Google Scholar] [DOI]
15 Early Sociability and Social Memory Impairment in the A53T Mouse Model of Parkinsonís Disease Are Ameliorated by Chemogenetic Modulation of Orexin Neuron Activity
Milos Stanojlovic,Jean Pierre Pallais Yllescas,Aarthi Vijayakumar,Catherine Kotz
Molecular Neurobiology. 2019;
[Pubmed]  [Google Scholar] [DOI]
16 Principles of Diffusion Kurtosis Imaging and its Role in Early Diagnosis of Neurodegenerative Disorders
Anas Arab,Anna Wojna-Pelczar,Amit Khairnar,Nikoletta Szabů,Jana Ruda-Kucerova
Brain Research Bulletin. 2018;
[Pubmed]  [Google Scholar] [DOI]
17 Are dementia with Lewy bodies and Parkinsonís disease dementia the same disease?
Kurt A. Jellinger,Amos D. Korczyn
BMC Medicine. 2018; 16(1)
[Pubmed]  [Google Scholar] [DOI]
18 Neural predictors of gait stability when walking freely in the real-world
Sara Pizzamiglio,Hassan Abdalla,Usman Naeem,Duncan L. Turner
Journal of NeuroEngineering and Rehabilitation. 2018; 15(1)
[Pubmed]  [Google Scholar] [DOI]
19 Biomarkers for Parkinsonís Disease: Recent Advancement
Sharvari Lotankar,Kedar S Prabhavalkar,Lokesh K Bhatt
Neuroscience Bulletin. 2017; 33(5): 585
[Pubmed]  [Google Scholar] [DOI]
20 Dementia with Lewy bodies and Parkinsonís disease-dementia: current concepts and controversies
Kurt A. Jellinger
Journal of Neural Transmission. 2017;
[Pubmed]  [Google Scholar] [DOI]


Read this article